Copper-Infused Products Can Reduce C-Difficile, Hospital Bacteria & Other Multidrug-Resistant Organisms

Posted by:
The best lawyers are always inquisitive. Learning about advances in science & technology enable Doug Landau & his law school friend & top DC attorney Paul Bran stay on top of their game. Here they are after a recent program at the American Association for the Advancement of Sciences (“AAAS”) headquarters in Washington, D.C.

With a court date looming for an ABRAMS LANDAU client who contracted C-Difficile while working in the maintenance department of a Northern Virginia retirement facility, attorney Doug Landau was intrigued by an article in a recent issue of VIRGINIA BUSINESS. Titled, “Study shows effect of copper infused products,” it examined the results of the world’s largest clinical trial of copper against hospital acquired infections. The study was published in the American Journal of Infection Control and presented at the Infectious Diseases Society of America conference. Hospital acquired infections complicate the recovery of disabled workers compensation claimants, car crash clients and those seeking Social Security Disability benefits due to a permanent inability to work.

What did the study reveal? Copper infused hard surfaces and linens contributed to a 78% overall reduction in a host of multi drug resistant organisms and 83% reduction in C-Difficile!  C-Difficile is a difficult pathogen to treat successfully. It is contracted when health care workers come into contact with infected fecal matter and have compromised gut immune systems. The products tested are made by Richmond-Based Cupron and Norfolk-based EOS Surfaces. The bacteria kill rates showed the efficacy of the Copper infused products and their real-world applications. The EOS product is the only synthetic hard surface registered by the Environmental Protection Agency (“EPA”) as a bacterial sanitizer proved to kill 99.9% of bacteria within 2 hours of contact! To pass the EPA’s muster, the company had to submit 14,000 samples for testing. Landau is interested to see what Northern Virginia and Washington DC area Health Care and retirement facilities incorporate this technology into their anti-bacterial infection arsenal. He adds, “This could really help prevent further infections to clients of ABRAMS LANDAU who work in the health care field, retirement community or other jobs that expose them to these kinds of multidrug-resistant organisms.”